Company Search:
Advanced Search
Sponsored Links
Basilea Pharmaceutica Limited Company Snapshot
Basilea Pharmaceutica Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Basilea Pharmaceutica Limited with three other miscellaneous service companies in Europe: Adocia SAS of France (2015 sales of 36.94 million Euro [US$39.17 million] of which 100% was Regenerative Medicine), Weifa ASA of Norway (332.04 million Norwegian Kroner [US$38.92 million] ), and Cellectis SA which is based in France (56.39 million Euro [US$59.79 million] of which 101% was Therapeutics).

Sales Analysis. Basilea Pharmaceutica Limited reported sales of 51.65 million Swiss Francs (US$51.04 million) for the year ending December of 2015. This represents an increase of 21.5% versus 2014, when the company's sales were 42.50 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Basilea Pharmaceutica Limited
  Stock Performance Chart for Basilea Pharmaceutica Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 74.70
(Figures in Swiss Francs)
1 Week -2.1%   13 Weeks 4.0%  
4 Weeks 3.2%   52 Weeks -5.9%  
Basilea Pharmaceutica Limited Key Data:
  Ticker: BSLN Country: Switzerland
  Exchanges: GVA Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 51,654,000
(Year Ending Jan 2016).
Employees: 250
  Currency: Swiss Francs Market Cap: 882,234,863
  Fiscal Yr Ends: December Shares Outstanding: 11,810,373
  Share Type: Namenaktie Closely Held Shares: 290,652
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.